On the contrary, in other investigations performed on human ovarian cancer, TRAP1 downregulation resulted in the enhancement of invasion and EMT [260]; such a discrepancy implies that cancer stemness-related activities of TRAP1 may cardinally differ in various types of tumors. This evidence concerns the gene TRAP1 and ovarian cancer.